Drug samples in dermatology: A focus on underserved and under-resourced patients - 21/11/24
Doi : 10.1016/j.jaad.2024.10.028
Christopher Wachuku, MD, MS a, b, Jennifer Lucas, MD c, Christina Cruz, BA a, Susan Taylor, MD a, ⁎ 
a Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
b Department of Internal Medicine, Lankenau Medical Center, Main Line Health, Wynnewood, Pennsylvania
c Department of Dermatology, Cleveland Clinic, Cleveland, Ohio
∗Correspondence to: Susan Taylor, MD, Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, 3400 Civic Center Blvd, 7th Floor PCAM South, Rm 768, Philadelphia, PA 19104-5162.Department of DermatologyPerelman School of MedicineUniversity of Pennsylvania3400 Civic Center Blvd7th Floor PCAM SouthRm 768PhiladelphiaPA19104-5162
Sous presse. Épreuves corrigées par l'auteur.
Disponible en ligne depuis le Thursday 21 November 2024
Key words : drugs, health equity, medications, pharmaceuticals, skin of color, underserved
Abbreviation used : PDSs
| Funding sources: None. |
|
| Prior presentations: None. |
|
| Patient consent: Not applicable. |
|
| IRB approval status: Approved. |
© 2024
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?